Compound W

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the removal of common and plantar warts. Common warts are characterized by their rough, “cauliflower-like” appearance on the surface, while plantar warts are specifically located on the bottom of the foot, presenting with tenderness and an interruption of the footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed thoroughly prior to treatment. For optimal results, the wart may be soaked in warm water for approximately 5 minutes. After soaking, the area must be dried completely.

The medication is to be applied by gently squeezing the tube to dispense one drop at a time, ensuring that each wart is sufficiently covered. Following application, the treated area should be allowed to dry.

This procedure may be repeated once or twice daily as necessary, continuing until the wart is removed, with a maximum treatment duration of up to 12 weeks.

Contraindications

Use is contraindicated in the following situations:

Application on irritated skin or any area that is infected or reddened is prohibited due to the potential for exacerbating the condition. The product should not be applied to moles, birthmarks, warts with hair growing from them, genital warts, or warts located on the face or mucous membranes, as these may lead to adverse reactions or complications. Additionally, individuals with diabetes or poor blood circulation should not use this product, as it may pose significant risks to their health.

Warnings and Precautions

For external use only, this product is flammable and should be kept away from fire and flame.

It is contraindicated for use on irritated skin or any area that is infected or reddened. Additionally, the product should not be applied to moles, birthmarks, warts with hair growing from them, genital warts, or warts located on the face or mucous membranes. Caution is advised for individuals with diabetes or poor blood circulation, as use in these populations may pose additional risks.

Healthcare professionals should instruct patients to discontinue use and seek medical advice if discomfort persists.

To ensure safety, this product must be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center (1-800-222-1222) is recommended.

Side Effects

Patients using this product should be aware of several important safety warnings and precautions. The product is intended for external use only and is flammable; therefore, it should be kept away from fire and flame. It is contraindicated for use on irritated skin or any area that is infected or reddened. Additionally, it should not be applied to moles, birthmarks, warts with hair growing from them, genital warts, or warts on the face or mucous membranes. Patients with diabetes or poor blood circulation should also refrain from using this product.

During use, patients are advised to avoid contact with the eyes. In the event that the product comes into contact with the eyes, it is recommended to flush the eyes with water for 15 minutes. Inhalation of vapors should also be avoided to prevent respiratory discomfort.

Patients should discontinue use and consult a healthcare professional if discomfort persists. It is crucial to keep this product out of reach of children. In the case of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted at 1-800-222-1222.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Compound W (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center (1-800-222-1222) should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of Compound W (salicylic acid gel) in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as the absence of data necessitates careful consideration of individual patient factors. Monitoring for potential adverse effects is advisable, given the lack of established guidelines for this population.

Pregnancy

The safety of salicylic acid during pregnancy has not been established. Salicylic acid is contraindicated in pregnancy due to potential risks to the fetus. Therefore, use during pregnancy should be avoided unless the potential benefit justifies the potential risk to the fetus. Healthcare professionals are advised to carefully consider the risks and benefits when prescribing this medication to pregnant patients or women of childbearing potential.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help without delay. It is recommended to contact a Poison Control Center at 1-800-222-1222 for expert guidance on managing the situation.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Healthcare providers should be prepared to assess the patient's condition and implement appropriate management strategies based on the severity of symptoms and the specific substance involved.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to elucidate these aspects of nonclinical toxicology.

Postmarketing Experience

Skin discoloration has been reported in postmarketing experience, occurring during or after the use of the product. These events have been documented through voluntary reports and surveillance programs.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. In the event of swallowing the product, patients should seek medical assistance or contact a Poison Control Center immediately at 1-800-222-1222.

Patients should be instructed not to use the product on irritated skin or any area that appears infected or reddened. It is important to inform patients that the product should not be applied to moles, birthmarks, warts with hair growing from them, genital warts, or warts located on the face or mucous membranes. Additionally, patients with diabetes or poor blood circulation should be cautioned against using this product.

Healthcare providers should emphasize that if discomfort persists after using the product, patients should stop use and consult a doctor. Patients should also be made aware to avoid contact with their eyes while using the product; if contact occurs, they should flush the eye with water for 15 minutes. Furthermore, patients should be advised to avoid inhaling vapors from the product.

Lastly, it is essential to instruct patients to cap the product tightly and store it at room temperature, away from heat sources, to maintain its efficacy and safety.

Storage and Handling

The product is supplied in a tube format. It should be stored at room temperature, ensuring that it is kept away from excessive heat, specifically temperatures exceeding 37°C (99°F). To maintain hygiene and product integrity, it is recommended to wipe the tip of the tube with a paper towel between uses.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Compound W, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)